Agree To Buy Monster Beverage At $62.50, Earn 6.4% Using Options

A January 2028 MNST put with a $62.50 strike is trading with a $4.00 premium, which equates to a 3.1% annualized return; if exercised the seller's effective cost basis would be $58.50 per share. With Monster Beverage trading at $77.56, assignment would require a ~19.3% share decline, and the stock's trailing 12-month volatility is 23% (250 trading days). The write-up frames the trade as limited upside (premium only unless assignment occurs) and highlights volatility and historical price placement as inputs for assessing reward versus risk.

Analysis

Market structure: The specific trade discussed (selling Jan 2028 MNST $62.50 puts for $4 → $58.50 effective cost if assigned) benefits cash-rich income seekers but offers only ~3.1% annualized return versus MNST's 23% trailing realized volatility — an unfavourable risk/reward unless the seller wants to own the equity. Counterparties (put buyers) win if MNST drops >19% from $77.56; broader market impact is negligible — no direct supply shock and minimal cross-asset transmission to bonds/FX beyond cyclical risk‑off flows.

Risk assessment: Tail risks include regulatory action on stimulants/sugar or a Coca‑Cola/ distribution disruption (a known material dependency) that could plausibly trigger a >20% drawdown; supply shocks (can or sweetener shortages) could shave 8–15% off margins. Time horizons: days — option premium and IV moves; months — consumer spending/earnings cadence; years — brand pricing power and category growth. Catalysts: quarterly volumes, FDA/regulatory headlines, aluminum prices, and Coca‑Cola distribution updates.

Trade implications: Avoid naked long-dated puts for a 3.1% yield unless prepared to own at $58.50 and hold >2 years. Prefer defined-risk option structures: cash‑secured puts sized ≤2% portfolio, 12–24 month debit put spreads, or buy-side plays on pullbacks (buy equity or LEAPS). Consider relative value vs legacy soda (MNST long / KO or PEP short) to isolate energy‑drink growth premium.

Contrarian angles: The market may underprice Monster's pricing power and youth demographic stickiness — a 10–20% pullback could be a durable buying opportunity, not fundamental impairment. Conversely, implied compensation for long-term assignment is low: require >5% annualized premium or use put credit spreads; unintended consequence of selling puts now is capital being locked at an unattractive entry if macro weakens, turning a small yield into a poor IRR.

Key Decisions for Investors

• If willing to own MNST, sell cash-secured Jan 2028 $62.50 puts sized to 1–2% of portfolio only if assignment cost $58.50 is acceptable; otherwise reject — target realized IRR >=5% (current =3.1%).
• Alternative defined-risk: sell a Jan 2028 $62.50/$55 put credit spread (receive premium but cap downside) sized 1–2% portfolio to limit max loss to ~$7.50 per share if assigned; use if implied vol > realized vol by ≥3–5 vol points.
• Buy-the-dip equity entry: accumulate MNST on pullback below $70 (initial 1–2% position), add to 3–4% total core weight if price re-tests $62–65; set tactical stop-loss 10% and 12–24 month target +20–30%.
• Relative trade: establish long MNST / short KO (or PEP) 1:1 exposure sized 1–2% portfolio to capture category growth vs legacy soda over 6–12 months; rebalance on ±10% moves.
• If directional levered exposure desired, buy 18–24 month LEAPS calls (e.g., $80 strike) for up to 30% of intended equity exposure rather than selling low-yield long-dated puts; exit or hedge if implied vol rises >5 vol points or sales volumes weaken two consecutive quarters.